EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Population-Based Real-World Outcomes of Post-Operative Adjuvant Brain Cavity Radiotherapy Versus Observation

Zhang Hao Jim Li iD, Linden Lechner iD, Jennifer Wang iD, Nan Hui Susan Yao, Andrew Lee, Serge Makarenko, Mostafa Fatehi, Herve H F Choi iD, Ermias Gete, Fred Hsu, Waseem Sharieff iD, Shrinivas Rathod und 6 weitere

Current Oncology · 2025

DOI: 10.3390/curroncol32060345 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Current Oncology, 2025. Verfasst von Zhang Hao Jim Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 4E6, Canada. Hauptthemen laut MEDLINE: Brain Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the factors influencing the outcomes of patients who underwent surgical resection of brain metastasis followed by either surveillance or post-operative stereotactic radiosurgery/fractionated radiotherapy (SRS/SFRT), a retrospective multi-center chart review was performed on all patients who underwent brain metastases resection in British Columbia between 2018 and 2020. Patients with prior whole-brain radiotherapy were excluded from the study. The primary study endpoints included local recurrence, distant intracranial control, radionecrosis (RN), leptomeningeal disease (LMD), and overall survival (OS). The Kaplan–Meier method was used to analyze survival. The Cox proportional hazards model was used to perform univariable (UVA) and multivariable (MVA) analyses to identify predictors of local control. A total of 113 patients met the inclusion criteria. A total of 31 patients received adjuvant SRS/SFRT to the surgical cavity, while 82 went on observation. The 12-month local control was 69% (50–88%) for the SRS/SFRT cohort and 31% (18–45%) for the observation cohort (p < 0.001). The 12-month distant intracranial control was 44% (26–63%) for the SRS/SFRT cohort and 46% (30–62%) for the observation cohort (p = 0.9). Sensitivity analysis did not show a difference in overall survival (p = 0.6). En bloc resection (p < 0.05), resection without residual disease (p < 0.05), and SRS/SFRT (p < 0.001) were predictive of local control on MVA. Three SRS/SFRT patients (10%) and two observation patients (2%) developed LMD. Four SRS/SFRT patients experienced RN (13%), with no grade 3 or higher toxicities observed. Post-operative SRT outcomes based on real-world population data are consistent with the data from clinical trials and support the established guidelines. For patients requiring surgical resection of brain metastasis, en bloc gross total resection should be encouraged when feasible to reduce local recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsHumansMaleFemaleMiddle AgedAgedRadiotherapy, AdjuvantRetrospective StudiesTreatment OutcomeAdultRadiosurgeryAged, 80 and over

Stichwörter der Autor:innen

CNS metastasisleptomeningeal diseasepalliative radiotherapyradionecrosisstereotactic radiosurgerystereotactic radiotherapy

Autor:innen und Institutionen

  • Division of Radiation Oncology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 4E6, Canada.
  • Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Division of Neurosurgery, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
  • Department of Medical Physics, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
  • Data and Analytics, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada.

ORCID-Profile: Zhang Hao Jim Li, Linden Lechner, Jennifer Wang, Herve H F Choi, Waseem Sharieff, Jessica Chan, Alan Nichol, Justin Oh

Zitieren

APA

Li, Z. H. J., Lechner, L., Wang, J., Yao, N. H. S., Lee, A., Makarenko, S., Fatehi, M., Choi, H. H. F., Gete, E., Hsu, F., Sharieff, W., Rathod, S., Carolan, H., Chan, J., Ma, R., Nichol, A., Nghiem, T., & Oh, J. (2025). Population-Based Real-World Outcomes of Post-Operative Adjuvant Brain Cavity Radiotherapy Versus Observation. Current Oncology. https://doi.org/10.3390/curroncol32060345

Vancouver

Li ZHJ, Lechner L, Wang J, Yao NHS, Lee A, Makarenko S, et al. Population-Based Real-World Outcomes of Post-Operative Adjuvant Brain Cavity Radiotherapy Versus Observation. Current Oncology. 2025. doi:10.3390/curroncol32060345

BibTeX
@article{Li2025,
  author = {Li, Zhang Hao Jim and Lechner, Linden and Wang, Jennifer and Yao, Nan Hui Susan and Lee, Andrew and Makarenko, Serge and Fatehi, Mostafa and Choi, Herve H F and Gete, Ermias and Hsu, Fred and Sharieff, Waseem and Rathod, Shrinivas and Carolan, Hannah and Chan, Jessica and Ma, Roy and Nichol, Alan and Nghiem, Thi and Oh, Justin},
  title = {Population-Based Real-World Outcomes of Post-Operative Adjuvant Brain Cavity Radiotherapy Versus Observation},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32060345}
}
Kostenlos starten →